Ho TC - Search Results

1

Ho TC, Shimada N, Tius MA, Nikas SP, Zhang W, Makriyannis A. Ho TC, et al. J Org Chem. 2017 Aug 4;82(15):7839-7849. doi: 10.1021/acs.joc.7b00988. Epub 2017 Jul 17. J Org Chem. 2017. PMID: 28677397

2

Chain Substituted Cannabilactones with Selectivity for the CB2 Cannabinoid Receptor.

Alapafuja SO, Nikas SP, Ho TC, Tong F, Benchama O, Makriyannis A. Alapafuja SO, et al. Among authors: ho tc. Molecules. 2019 Oct 1;24(19):3559. doi: 10.3390/molecules24193559. Molecules. 2019. PMID: 31581433 Free PMC article.

3

Synthesis of Functionalized Cannabilactones.

Liu Y, Ho TC, Baradwan M, Pascual Lopez-Alberca M, Iliopoulos-Tsoutsouvas C, Nikas SP, Makriyannis A. Liu Y, et al. Among authors: ho tc. Molecules. 2020 Feb 6;25(3):684. doi: 10.3390/molecules25030684. Molecules. 2020. PMID: 32041131 Free PMC article.

4

Oxa-adamantyl cannabinoids.

Ho TC, Tius MA, Nikas SP, Tran NK, Tong F, Zhou H, Zvonok N, Makriyannis A. Ho TC, et al. Bioorg Med Chem Lett. 2021 Apr 15;38:127882. doi: 10.1016/j.bmcl.2021.127882. Epub 2021 Feb 24. Bioorg Med Chem Lett. 2021. PMID: 33636308

5

Corrigendum to "Oxa-adamantyl cannabinoids" [Bioorg. Med. Chem. Lett. 38 (2021) 127882].

Ho TC, Mullins JJ, Tius MA, Nikas SP, Tran NK, Tong F, Zvonok N, Makriyannis A. Ho TC, et al. Bioorg Med Chem Lett. 2022 Sep 15;72:128836. doi: 10.1016/j.bmcl.2022.128836. Epub 2022 Jul 5. Bioorg Med Chem Lett. 2022. PMID: 35803774 No abstract available.

6

Effects of the cannabinoid CB₁-receptor neutral antagonist AM4113 and antagonist/inverse agonist rimonabant on fentanyl discrimination in male rats.

AlKhelb D, Kirunda A, Ho TC, Makriyannis A, Desai RI. AlKhelb D, et al. Among authors: ho tc. Drug Alcohol Depend. 2022 Nov 1;240:109646. doi: 10.1016/j.drugalcdep.2022.109646. Epub 2022 Sep 26. Drug Alcohol Depend. 2022. PMID: 36191533

7

Blockade of CB1 or Activation of CB2 Cannabinoid Receptors Is Differentially Efficacious in the Treatment of the Early Pathological Events in Streptozotocin-Induced Diabetic Rats.

Spyridakos D, Mastrodimou N, Vemuri K, Ho TC, Nikas SP, Makriyannis A, Thermos K. Spyridakos D, et al. Among authors: ho tc. Int J Mol Sci. 2022 Dec 23;24(1):240. doi: 10.3390/ijms24010240. Int J Mol Sci. 2022. PMID: 36613692 Free PMC article.

8

Effects of cannabinoid agonists and antagonists in male rats discriminating the synthetic cannabinoid AM2201.

AlKhelb D, Burke EL, Zvonok A, Iliopoulos-Tsoutsouvas C, Georgiadis MO, Jiang S, Ho TC, Nikas SP, Makriyannis A, Desai RI. AlKhelb D, et al. Among authors: ho tc. Eur J Pharmacol. 2023 Dec 5;960:176168. doi: 10.1016/j.ejphar.2023.176168. Epub 2023 Oct 29. Eur J Pharmacol. 2023. PMID: 38059442

9

Large library docking for cannabinoid-1 receptor agonists with reduced side effects.

Tummino TA, Iliopoulos-Tsoutsouvas C, Braz JM, O'Brien ES, Stein RM, Craik V, Tran NK, Ganapathy S, Liu F, Shiimura Y, Tong F, Ho TC, Radchenko DS, Moroz YS, Rosado SR, Bhardwaj K, Benitez J, Liu Y, Kandasamy H, Normand C, Semache M, Sabbagh L, Glenn I, Irwin JJ, Kumar KK, Makriyannis A, Basbaum AI, Shoichet BK. Tummino TA, et al. Among authors: ho tc. bioRxiv [Preprint]. 2024 Feb 28:2023.02.27.530254. doi: 10.1101/2023.02.27.530254. bioRxiv. 2024. PMID: 38328157 Free PMC article. Preprint.

10

Genetics in neovascular age-related macular degeneration susceptibility and treatment response to anti-VEGF intravitreal injection: A case series study.

Chang FY, Huang CH, Yang CH, Chang JT, Yang CM, Ho TC, Hsieh YT, Lai TT, Lin CW, Lin CP, Chen YC, Lai YJ, Chen PL, Hsu JS, Chen TC. Chang FY, et al. Among authors: ho tc. Clin Exp Ophthalmol. 2024 May 16. doi: 10.1111/ceo.14388. Online ahead of print. Clin Exp Ophthalmol. 2024. PMID: 38757252

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

395 results

Search Page